323 results
Page 4 of 17
6-K
EX-99.1
pxpls7p
30 Jul 21
Current report (foreign)
4:01pm
6-K
EX-99.1
foqd 7gqa7pk
29 Jul 21
Current report (foreign)
10:48am
6-K
EX-99.2
6q0rjpvzw2l
29 Jul 21
Current report (foreign)
10:48am
6-K
EX-99.3
3c6yjn0 ypf
30 Jun 21
Sanofi launches dedicated vaccines mRNA Center of Excellence
5:17pm
6-K
EX-99.4
h6vykwkxdt8ox7j6pm
30 Jun 21
Sanofi launches dedicated vaccines mRNA Center of Excellence
5:17pm
6-K
EX-99.5
bsomdcs
30 Jun 21
Sanofi launches dedicated vaccines mRNA Center of Excellence
5:17pm
6-K
EX-99.3
fangoormrr6trmh7
8 Jun 21
Sanofi launches its new global employee share ownership plan
1:31pm
6-K
EX-99.3
rjk63ep17fe9
21 May 21
Sanofi to showcase data from its transformative oncology pipeline at 2021 ASCO Meeting
4:16pm
6-K
EX-99.1
q84id4svjdyf
19 Mar 21
Phase 3 trial of Libtayo® (cemiplimab) monotherapy in advanced cervical cancer stopped early for positive result on overall survival
3:49pm
6-K
EX-99.2
qhn2of7d42mrin
8 Mar 21
Filing of the 2020 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
4:20pm
6-K
EX-99.1
ceoqmocd8nr 6dugd
23 Feb 21
Current report (foreign)
4:26pm
6-K
EX-99.1
mus87lhwft2c2s 4bip
19 Feb 21
Current report (foreign)
1:48pm
6-K
EX-99.1
4hr93yg2js6wxskmg
11 Feb 21
FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma
3:17pm
6-K
EX-99.3
wv4 hcxamj1l16a
11 Dec 20
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the elderly
3:25pm
6-K
EX-99.1
mf7w 4y031sh5it8
3 Dec 20
Current report (foreign)
1:40pm
6-K
EX-99.2
xr1qz83qa9jxdcgi9yqw
4 Nov 20
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
3:27pm
6-K
EX-99.1
54yjbahh5segmiqxuz2k
4 Nov 20
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
3:27pm
6-K
EX-99.2
iv93ab
30 Oct 20
Praluent® (alirocumab) continues to be available in European countries where it is approved for use and for sale
5:09pm